HYPOTHALAMIC OBESITY
Clinical trials for HYPOTHALAMIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new HYPOTHALAMIC OBESITY trials appear
Sign up with your email to follow new studies for HYPOTHALAMIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise for obesity after brain tumor therapy
Disease control CompletedThis study tested whether exenatide, a diabetes medication, can help adults with severe weight gain caused by treatment for a rare brain tumor called craniopharyngioma. 42 participants received either exenatide or a placebo, along with lifestyle advice, for 6 months. The main goa…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
New pill shows promise for rare Brain-Related obesity
Disease control CompletedThis study tested an experimental drug called LB54640 in 28 people aged 12 and older with hypothalamic obesity, a condition where brain injury causes rapid weight gain. Participants took either the drug or a placebo daily for 14 weeks, then could continue on the drug for up to a …
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC